Rock Springs Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-321,050
| Closed | -$9.29M | – | 139 |
|
|
2021
Q4 | $9.29M | Buy |
321,050
+2,600
| +0.8% | +$75.3K | 0.21% | 95 |
|
|
2021
Q3 | $9.54M | Buy |
318,450
+3,100
| +1% | +$92.9K | 0.2% | 109 |
|
|
2021
Q2 | $8.37M | Buy |
315,350
+4,400
| +1% | +$117K | 0.17% | 121 |
|
|
2021
Q1 | $9.67M | Buy |
310,950
+53,700
| +21% | +$1.67M | 0.21% | 119 |
|
|
2020
Q4 | $8.46M | Sell |
257,250
-264
| -0.1% | -$8.68K | 0.18% | 118 |
|
|
2020
Q3 | $8.99M | Buy |
+257,514
| New | +$8.99M | 0.23% | 107 |
|